Wisdom of Ayurveda in perceiving diabetes: Enigma of therapeutic recognition

Current Science

Volumn 88, Issue 7, 2005, Pages 1043-1051

  Tiwari, Ashok K ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24144458328     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. MacFarlance, I. A., Bliss, M., Jackson, J. G. L. and Williams, G., The history of diabetes mellitus. In Textbook of Diabetes (eds Pickup, J. and Williams, G.), Blackwell, London 1997, 2nd edn, vol. I, pp 1.1-1.21.
2. Willis, T., Pharmaceutica Rationales Siva Diatriba de Medicamentorium Operationitus in humano Corpore, London, 2 vols, pp. 1674-1675.
3. Frank, L. L., Diabetes mellitus in the text of old Hindu medicine. Am. J. Gastroenterol., 1957, 27, 76-71.
4. Rollo, J., An account of two cases of the diabetes mellitus, with remarks as they arose during the progress of the cure. C. Dilly, London, 1797.
5. Dobson, M., Experiments and observations on the urine in diabetes. Med. Obs. Inq., 1776, 5, 298-316.
6. Marx, J., Unraveling the cause of diabetes. Science, 2002, 296, 686-689.
7. Ramachandran, A. et al., For the Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India; National Urban Diabetes Survey. Diabetologia, 2001, 44, 1094-1101.
8. Mohan, V., Shanthirani, C. S. and Deepa, R., Glucose intolerance (diabetes and IGT) in a selected south Indian population with special reference to family history, obesity, and lifestyle factors - The Chennai Urban Population Study (CUPS 14). J. Assoc. Physicians India, 2003, 51, 771-777.
9. Pradeepa, R. and Mohan, V., The changing scenario of the diabetes epidemic; implications for India. Indian J. Med. Res., 2002, 116, 121-132.
10. Upadhyaya, Y. (ed.), In Madhavnidanam of Sri Madavakara, Part. II. The Kashi Sanskrit Series 158, Chaukhambha Sanskrit Sansthan, Varanasi, 1993, 22nd edn, pp. 1-27.
11. Hellstrom, H. R., The altered homeostatic theory: A holistic approach to multiple diseases, including atherosclerosis, ischemic diseases, and hypertension. Med. Hypotheses, 1999, 53, 194-199.
12. Nedelcu, A. M., Marcu, O. and Michod, R. E., Sex as a response to oxidative stress: a two-fold increase in cellular reactive oxygen species activates sex genes Proc. R. Soc. London, Ser. B, 2004, 271, 1591-1596.
13. Tiwari, A. K., Antioxidants: New-generation therapeutic base for treatment of polygenic disorders. Curr. Sci., 2004, 86, 1092-1102.
14. Tiwari, A. K., Imbalance in antioxidant defense and human diseases: Multiple approach of natural antioxidants therapy. Curr. Sci., 2001, 81, 1179-1187.
15. Wu, X., Beecher, G. R., Holden, J. M., Haytowitz, D. B., Gebhardt, S. E. and Prior, R. L., Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J. Agric. Food Chem., 2004, 52, 4026-4037.
16. Fenglin, H., Ruili, L., Bao, H. and Liang, M., Free radical scavenging activity of extracts prepared from fish leaves of selected Chinese medicinal plants. Fitoterapia, 2004, 75, 14-23.
17. McCune, L. M. and Johns, T., Antioxidant activity of medicinal plants associated with the symptoms of diabetes mellitus used by the indigenous peoples of the North American Boreal forest. J. Ethnopharmacol., 2002, 82, 197-205.
18. Vahabzadeh, F., Mehranian, M. and Mofarrah, E., Antioxidant activities of Pistachio hulls. JAOCS, 2004, 81, 621-622.
19. Tiwari, A. K. and Rao, J. M., Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Curr. Sci., 2002, 83, 30-38.
20. Laight, D. W., Carrier, M. J. and Anggard, E. E., Antioxidants, diabetes, and endothelial dysfunction. Cardiovasc. Res., 2000, 47, 457-464.
21. Evans, J. L., Goldfine, I. D., Maddux, B. A. and Grodsky, G. M., Oxidative stress and stress activated signaling pathways; A unifying hypothesis of type 2 diabetes. Endocrine Rev., 2002, 23, 599-622.
22. Dhalla, N. S., Liu, X., Panagia, V. and Takeda, N., Sub cellular modeling, and heart dysfunction in chronic diabetes. Cardiovasc. Res., 1998, 40, 239-247.
23. Jain, S. K., McVie, R. and Smith, T., Vitamin E supplementation restores glutathion and malonaldhyde to normal concentrations in erythrocytes of type-I diabetic children. Diabetes Care, 2000, 23, 1389-1394.
24. Perkiner, B. et al., In-vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca++ -ATPase activity in heart and liver of streptozotocin-diabetic rats: Comparison with vitamin E. The ADIC (Antioxidants in Diabetes Induced Complications) Study Group. Biochim. Biophys. Acta, 2002, 1588, 71-78.
25. Bailey, C. J., Potential new treatments for type-2 diabetes. Trends Pharmacol. Sci., 2000, 21, 259-265.
26. Daniel, M., The impediments preventing India from becoming a herbal giant. Curr. Sci., 2004, 87, 275-276.
27. Wen, D., Henning, S. J. and Hazolwood, R. L., Effect of diabetes on development of small intestinal enzymes in infant rats. Proc. Soc. Exp. Biol. Med., 1988, 187, 51-57.
28. Caspary, W. F., Rhein, A. M. and Creutzfeldt, W., Increase of intestinal brush border hydrolase in mucosa of streptozotocin-diabetic rats. Diabetologia, 1972, 8, 412-414.
29. Mooradian, A. D. and Thurman, J. E., Drug therapy of post-prandial hyperglycemia. Drugs, 1999, 57, 19-29.
30. Lebowitz, H. E., α-Glucosidase inhibitors as agents in treatment of diabetes. Diabetes Rev., 1998, 6, 132-145.
31. Johnston, P. S., Caniff, R. F., Hoogwerf, B. J., Santiago, J. V., Pi-Suryer, F. X. and Krol, A., Effect of carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients. Diabetes Care, 1994, 17, 20-29.
32. Asano, N., Oseki, K., Tomioka, E., Kizu, H. and Matsui, K., N-containing sugars from Morus alba and their glycosidase inhibitory activities. Carbohydr. Res., 1994, 259, 243-255.
33. Mastuda, H., Murakami, T., Yashiro, K., Yamahara, J. and Yashikawa, M., Antidiabetic principles from natural medicines IV. Aldose reductase and alpha-glucosidase inhibitors from roots of Salacia oblonga Wall (Celastraceae): Structure of a new friedelane-type triterpene, Kotalagenin 16-acetate. Chem. Pharm. Bull., 1999, 47, 1725-1729.
34. Yashikawa, M., Murakami, T., Yashiro, K. and Matsuda, H., Kotalanol, a potent alpha glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic Ayurvedic medicine Salacia reticulata. Chem. Pharm. Bull., 1998, 46, 1339-1340.
35. Jaglekar, G. V., Chaudhary, N. Y. and Aiaman, R., Effect of Indian medicinal plants on glucose absorption in mice. Indian J. Physiol. Pharmacol., 1959, 3, 76-77.
36. Yashikawa, M., Murakami, T., Kadoya, M., Liu, Murakami, N., Yamahara, J. and Matsuda, H., Medicinal food stuffs: IX, The inhibitors of glucose absorption from the leaves of Gymnema sylvestre R. BR (Asclepiadaceae): Structure of gymnemoside a and b. Chem. Pharm. Bull., 1997, 45, 1671-1676.
37. Saltiel, A. R., Putting the breaks on insulin signaling. N. Engl. J. Med., 2003, 349, 2560-2562.
38. Nandi, A., Kitamura, Y., Koh, C. R. and Accili, D., Mouse models of insulin resistance. Physiol. Rev., 2004, 84, 623-647.
39. Chakravarthy, B. K., Gupta, S., Gambhir, S. S. and Gode, K. D., Pancreatic beta cell regeneration. A novel antidiabetic mechanism of Pterocarpus marsupium Roxb. Indian J. Pharmacol., 1980, 12, 123-127.
40. Chakravarthy, B. K., Gupta, S. and Gode, K. D., Functional beta-cell regeneration in the islets of pancreas in alloxan induced diabetic rats by (-) epicatechin. Life Sci., 1982, 31, 2693-2697.
41. Chakravarthy, B. K., Gupta, S. and Gode, K. D., Antidiabetic effect of (-)-epicatechin. Lancet, 1982, 2, 272-273.
42. Sheehan, E. W., Zemaitis, M. A., Slatkin, D. J. and Schiff, Jr. P. L., A constituent of Pterocarpus marsupium, (-) epicatechin, as a potential antidiabetic agent. J. Natl. Prod., 1983, 46, 232-234.
43. Welihinda, J., Arvidson, G., Gylfe, E., Hellman, B. and Karlsson, E., The insulin releasing activity of the tropical plant Momordica charantia. Acta Biol. Med. Ger., 1982, 41, 1229-1240.
44. Ivorra, M. D., Paya, M. and Villar, A., Hypoglycemic, and insulin releasing effect of tormentic acid: a new hypoglycemic natural product. Planta Med., 1988, 54, 282-286.
45. Sauvaire, Y. et al., 4-Hydroxyisoleucine: A novel amino acid potentiator of insulin secretion. Diabetes, 1998, 47, 206-210.
46. Augusti, K. T. and Sheila, C. G., Antiproxide effect of S-allele cysteine sulfoxide, an insulin secretogague in diabetic rats. Experientia, 1996, 52, 115-120.
47. Kumar, R. V. and Augusti, K. T., Insulin sparing action of a leucocyanidin derivative isolated from Ficus bengalensis Linn. Indian J. Biochem. Biophys., 1994, 31, 73-76.
48. Tominaga, M. et al., Effect of seishin renshi-in and Gymnema sylvestre on insulin resistance in streptozotocin induced diabetic rats. Diabetes Res. Clin. Practice, 1995, 29, 11-17.
49. Grover, J. K., Vats, V. and Rathi, S. S., Antihyperglycemic effect of Eugenia jambolana and Tinospora cardifoia in experimental diabetes and their effects on key metabolic enzymes evolved in carbohydrate metabolism. J. Ethnopharmacol., 2000, 73, 461-470.
50. Okabayashi, Y. et al., Effect of Gymnema sylvestre. R. Br. on glucose homeostasis in rats. Diabetes Res. Clin. Practice, 1990, 9, 143-148.
51. Chattopadhyaya, R. R., Chattopadhyaya, R. N., Nandy, A. K., Poddar, G. and Maitra, S. K., The effect of fresh leaves of Azadiracta indica on glucose uptake and glycogen extent in the isolated rat hemi diaphragm. Bull. Calcutta Sch. Trop. Med., 1987, 35, 8-12.
52. Hossain, M. Z., Shibib, B. A. and Rahman, R., Hypoglycemic effects of Coccinia indica; Inhibition of key gluconeogenic enzyme, glucose-6-phosphatase. Indian J. Exp. Biol., 1992, 30, 418-420.
53. Shibib, B. A., Khan, L. A. and Rahman, R., Hypoglycemic activity of Coccinia indica and Momordica charantia in diabetic rats: Depression of hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphatase dehydrogenase. Biochem. J., 1993, 292, 267-270.
54. Kamble, S. M., Kamlakar, P. L., Vaidya, S. and Bambole, V. D., Influence of Coccinia indica on certain enzymes in glycolytic and lipolytic pathway in human diabetes. Indian J. Med. Sci., 1998, 52, 143-146.
55. Grover, J. K., Vats, V., Rathi, S. S. and Dawar, R., Traditional Indian antidiabetic plants attenuate renal hypertrophy, urine volume and albumin urea in streptozotocin-induced diabetic mice. J. Ethnopharmacol., 2001, 76, 233-238.
56. Grover, J. K., Rathi, S. S. and Vats, V., Amelioration of experimental diabetic neuropathy, and gastropathy in rats following oral administration of plant extracts. Indian J. Exp. Biol., 2002, 40, 273-276.
57. Rakieten, N., Rakieten, M. L. and Nadkarni, M. V., Studies on diabetogenic action of streptozotocin. Cancer Chemother. Rep., 1963, 29, 91-98.
58. Lenzen, S., Drinkgren, J. and Tiedg, M., Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med., 1996, 20, 463-466.
59. Tiedge, M., Lortz, S., Drinkgren, J. and Lenzens, S., Relation between antioxidant enzyme gene expression and antioxidant defense status of insulin producing cells. Diabetes, 1997, 46, 1733-1742.
60. Miyake, Y., Yamamoto, K., Tsujihara, N. and Osawa, T., Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids, 1998, 33, 689-695.
61. Grover, J. K., Yadav, S. and Vats, V., Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol., 2002, 81, 81-100.
62. Sharma, P. V., Classical Uses of Medicinal Plants, Haridas Ayurveda Series 4, Chaukhambha Visvabharati Publication, Varanasi, 1996, p. 169.
63. Tiwari, A. K., Srinivas, P. V., Praveen Kumar, S. and Rao, J. M., Free-radical scavenging active components from Cedrus deodara. J. Agric. Food Chem., 2001, 49, 4642-4645.
64. Rao, J. M., Tiwari, A. K., Srinivas, P. V., Yadav, J. S. and Raghavan, K. V., Use of two plant phenols in the treatment of arteriosclerosis. United States Patent No. (2002) 6458831.
65. Cornwell, T., Cohick, W. and Raskin, I., Dietary phytoestrogens, and health. Phytochemistry, 2004, 65, 995-1016.
66. Westcott, N. D. and Muir, A. D., Overview of flax lignans. Int. News Fats, Oils, Related Mater. (INFORM), 2000, 11, 118-121.
67. Medicinal Plants of India, Arya Vaidyasala, Kotakkal (India) (eds), Orient Longman, 1995, vol. 2, p. 330,
68. Medicinal Plants of India, and vol. 3, p. 185.
69. Rao, R. J., Tiwari, A. K., Sampath Kumar, U., Reddy, S. V., Ali, A. Z. and Rao, J. M., Novel 3-0-acyl mesquitol analogues as free-radical scavengers and enzyme inhibitors; synthesis, biological evaluation and structure activity relationship. Bioorg. Med. Chem. Lett., 2003, 13, 2777-2780.
70. Borges, F., Fernandes, E. and Roleira, F., Progress towards the discovery of xanthine oxidase inhibitors. Curr. Med. Chem., 2002, 9, 195-217.
71. Ahmad, F., Khalid, P., Khan, M. M., Rastogi, A. K. and Kidwai, J. R., Insulin-like activity in (-) epicatechin. Acta Diabetol. Lat., 1989, 26, 291-300.
72. Reddy, S. V., Tiwari, A. K., Kumar, S. P., Rao, R. J. and Rao, J. M., Free-radical scavenging, enzyme inhibitory constituents from antidiabetic traditional Indian medicinal plant Hydnocarpus wightiana Blume. Phytother. Res., 2004, 18, in press.
73. Kim, J. S., Kwan, C. S. and San, K., Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci. Biotechnol. Biochem., 2000, 64, 2458-2461.
74. Zarzuelo, A., Jimenez, I., Gamez, M. J., Utrilla, P., Fernandez, I., Toroes, M. I. and Osuno, I., Effect of luteolin-5-O-β-rutinoside in streptozotocin induced diabetic rats. Life Sci., 1996, 58, 2311-2316.
75. Reglero, A., Carretero, M. I. and Cabezas, J. A., Increased serum L-fucosidase and β-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric ulcer patients. Clin. Chem. Acta, 1980, 103, 155-158.
76. Alhadeff, J. A. and Holzinger, R. I., Characterization of β-hexosaminidase from liver and sera of diabetic patients and control. Biochem. Med., 1982, 27, 214-225.
77. Agardh, C. D., Agardh, E., Isaksson, A. and Huttberg, B., Association between urinary N-acetyl-β-D-glucosaminidase and its isoenzyme pattern and microangiopathy in type-I diabetes mellitus. Clin. Chem., 1991, 37, 1696-1699.
78. Mandic, L. J. and Filipovic, D., Changes in isoenzymes of serum N-acetyl-β-D-glucosaminidase in relation to different types of diabetes. Biochem. Mol. Biol. Int., 1998, 45, 545-554.
79. Schutltz, C. J., Dalton, R. N., Neil, H. A. W., Bahu-Konopelska, J. and Dunger, D. B., Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminurea in first few years after diagnosis of type-1 diabetes. Diabetologia, 2002, 44, 224-229.
80. Muller, D., Sievers, E. and Eggest, P., Influences of hyperfiltration on the measurement of urinary N-acetyl-β-D-glucosaminidase. Pediatr. Nephrol., 1999, 13, 519-523.
81. Aoyagi, T. et al., Nagstatin, a new inhibitor of N-acetyl-β-D- glucosaminidase, produced by Streptomycese amakusaensis. MG-846-fF3. Taxonomy, production, isolation, physico-chemical properties, and biological activities. J. Antibiot., 1992, 45, 1404-1408.
82. Tanne, J. H., FDA chief wants other rich countries to share drug development cost. Br. Med. J., 2003, 327, 830.
83. Iaccarino, M., Mastering science in the South. EMBO Rep., 2004, 5, 437-441.
84. Ernst, E., Herbal medicines put into context their cure entails risk, but probably fewer than with synthetic drugs. Br. Med. J., 2003, 327, 881-882.
85. Brevoort, P., The booming US botanical market. A new overview. Herbalgram, 1998, 44, 33-46.
86. Ernst, E., Herbal medicines: Where is the evidence? Br. Med. J., 2000, 321, 395-396.
87. Verma, I. M., Biopiracy: Distrust widens the rich-poor divide. Mol. Ther., 2002, 5, 95.
88. Edwards, R., No remedy in sight for herbal ransacks. New Sci., 2004, 181, 10-11.
89. Brake, M., Herbal healing. Chem. Br., 2003, 39, 27-29.